Elezanumab(ABT-555) is a potent human anti-RGMa monoclonal antibody.Elezanumab exerts its inhibitory effect on RGMa-mediated BMP signaling through the SMAD1/5/8 pathway, with an IC50 of approximately 97 pM.Elezanumab promotes neuroregeneration, neuroprot
CAS Number:
[1791416-49-3]
Target:
AE12-1Y-QL , ABT-555
* VAT and and shipping costs not included. Errors and price changes excepted